MedTrace Logo

Parathyroid Vascularization During Total Thyroidectomy Using Indocyanine Green Angiography

NCT05328076 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2024-07-05

No results posted yet for this study

Summary

Prospective, observational, single-center study about the use of indocyanine green angiography during total thyroidectomy.

The main objective of the study is to identify a quantitative score of parathyroid vascularization as an outcome of angiography that correlates with the absence of postoperative hypoparathyroidism.

It is planned to enroll 66 patients.

Conditions

Interventions

DRUG

Indocyanine green

Indocyanine green is used to perform intraoperative angiography.

DEVICE

SPY Portable Handheld Imaging (SPY-PHI)

The device is used to perform intraoperative angiography.

Sponsors & Collaborators

  • IRCCS San Raffaele

    lead OTHER

Principal Investigators

  • Riccardo Rosati, Prof. · San Raffaele Hospiral

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2023-01-19
Completion
2023-01-19
FDA Drug
Yes
FDA Device
Yes

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05328076 on ClinicalTrials.gov